Cleared Traditional

CAT-3 CATECHOLAMINE ASSAY KIT (K855214) - FDA 510(k) Clearance

Class I Chemistry device.

K855214 · Whale Scientific, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 1986
Decision
74d
Days
Class 1
Risk

K855214 is an FDA 510(k) clearance for the CAT-3 CATECHOLAMINE ASSAY KIT. Classified as Chromatographic/fluorometric Method, Catecholamines (product code CHQ), Class I - General Controls.

Submitted by Whale Scientific, Inc. (Commerce City, US). The FDA issued a Cleared decision on March 14, 1986 after a review of 74 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1165 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Whale Scientific, Inc. devices

Submission Details

510(k) Number K855214 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 30, 1985
Decision Date March 14, 1986
Days to Decision 74 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
14d faster than avg
Panel avg: 88d · This submission: 74d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code CHQ Chromatographic/fluorometric Method, Catecholamines
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1165
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.